Ceramide synthase is known to be enhanced in LPS-mediated septic shock in Cers2-deficient mice [49], and inhibition of ceramide synthesis prevented diabetes, steatosis, and cardiovascular disease in rodents [50]. The gene discussed is TLCD3B; the disease is diabetes mellitus.